anticancer agents (National Institute of Pharmaceutical Education and Research/Indian Institute of Chemical Technology)

N/A

Report date: 2025/01/26 16:20:04
NME

Base Information

Drug Nameanticancer agents (National Institute of Pharmaceutical Education and Research/Indian Institute of Chemical Technology)
Drug Alias NamePI3K-delta inhibitors (National Institute of Pharmaceutical Education and Research/Indian Institute of Chemical Technology)VJR-TZ-18
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphatidylinositol 3 kinase delta inhibitors
TargetsPhosphatidylinositol 3 kinase delta
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNational Institute of Pharmaceutical Education and Research SAS
China Registration ClassN/A

Develop Information

Active CompaniesIndian Institute of Chemical TechnologyNational Institute of Pharmaceutical Education and Research SAS
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A